Mosafe Tablet
Mosapride
2.5mg
Glenmark Pharmaceuticals Ltd.
| Pack size | 10's |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 3.77 NPR |
Available as:
Indications
Mosafe Tablet is used for:
Disorders associated with reduced gastrointestinal motility
Adult Dose
Oral
Disorders associated with reduced gastrointestinal motility
Adult: As anhydrous citrate: 5 mg tid.
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Continuous admin of this drug is not recommended if no improvement in GI symptoms is observed after 2 wk of admin. Elderly, renal impairment, hepatic impairment.
Pregnancy-Lactation
Interactions
Mosapride concentration increased by erythromycin. May increase risk of QT prolongation with QT prolonging drugs.
Adverse Effects
Side effects of Mosapride :
Diarrhoea, abdominal pain; dizziness; constipation; headache; insomnia; nausea.
Mechanism of Action
Mosapride is a 5-HT4 receptor agonist which increases the release of acetylcholine and stimulates GI motility. It also has 5-HT3 antagonist properties.
Note
Mosafe 2.5mg Tablet manufactured by Glenmark Pharmaceuticals Ltd.. Its generic name is Mosapride. Mosafe is availble in Nepal.
Farmaco Nepal drug index information on Mosafe Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.